Me Today
Market Cap
NZ$33.0m
Last Updated
2021/01/26 06:01 UTC
Data Sources
Company Financials
Executive Summary
Me Today Limited, through its subsidiaries, operates as a health and wellness company in New Zealand. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with weak fundamentals.
Share Price & News
How has Me Today's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MEE is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: MEE's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
-14.6%
MEE
3.4%
NZ Healthcare
3.9%
NZ Market
1 Year Return
n/a
MEE
7.2%
NZ Healthcare
10.6%
NZ Market
Return vs Industry: Insufficient data to determine how MEE performed against the NZ Healthcare industry.
Return vs Market: Insufficient data to determine how MEE performed against the NZ Market.
Shareholder returns
| MEE | Industry | Market | |
|---|---|---|---|
| 7 Day | -14.6% | 3.4% | 3.9% |
| 30 Day | 2.7% | 2.2% | 3.2% |
| 90 Day | -1.3% | 9.7% | 11.0% |
| 1 Year | n/a | 9.6%7.2% | 14.7%10.6% |
| 3 Year | n/a | 69.3%56.9% | 56.9%36.1% |
| 5 Year | n/a | 53.4%32.9% | 112.7%61.1% |
Long-Term Price Volatility Vs. Market
How volatile is Me Today's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 months ago | Simply Wall St
We're Hopeful That Me Today (NZSE:MEE) Will Use Its Cash WiselyValuation
Is Me Today undervalued compared to its fair value and its price relative to the market?
4.24x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate MEE's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate MEE's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: MEE is unprofitable, so we can't compare its PE Ratio to the XO Healthcare industry average.
PE vs Market: MEE is unprofitable, so we can't compare its PE Ratio to the NZ market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MEE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MEE is overvalued based on its PB Ratio (4.2x) compared to the NZ Healthcare industry average (2.8x).
Next Steps
Future Growth
How is Me Today forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
17.4%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Me Today has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine Me Today's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Me Today competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Me Today performed over the past 5 years?
-132.3%
Last years earnings growth
Earnings and Revenue History
Quality Earnings: MEE is currently unprofitable.
Growing Profit Margin: MEE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if MEE's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare MEE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MEE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).
Return on Equity
High ROE: MEE has a negative Return on Equity (-80.41%), as it is currently unprofitable.
Next Steps
Financial Health
How is Me Today's financial position?
Financial Position Analysis
Short Term Liabilities: MEE's short term assets (NZ$8.1M) exceed its short term liabilities (NZ$930.0K).
Long Term Liabilities: MEE's short term assets (NZ$8.1M) exceed its long term liabilities (NZ$154.0K).
Debt to Equity History and Analysis
Debt Level: MEE is debt free.
Reducing Debt: MEE had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MEE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MEE has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 103.1% each year.
Next Steps
Dividend
What is Me Today current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MEE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MEE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MEE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MEE's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MEE's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.8yrs
Average board tenure
CEO
Michael Kerr
0.83
Tenure
NZ$154,500
Compensation
Mr. Michael Kerr is Co-Founder and has been Director and Chief Executive Officer at Me Today Limited since March 31, 2020. Mr. Kerr has worked in sales and marketing roles for several local and multination...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 0.83yr | NZ$154.50k | no data | |
| Co-Founder | 0.83yr | NZ$60.00k | no data | |
| Co-Founder & Chairman | 0.83yr | no data | no data | |
| Independent Director | no data | NZ$79.00k | no data | |
| Independent Director | 0.83yr | no data | 0.086% NZ$ 28.3k | |
| Independent Director | 0.83yr | no data | no data |
0.8yrs
Average Tenure
Experienced Board: MEE's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: MEE only recently listed within the past 12 months.
Top Shareholders
Company Information
Me Today Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Me Today Limited
- Ticker: MEE
- Exchange: NZSE
- Founded: 2018
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: NZ$32.982m
- Shares outstanding: 412.28m
- Website: https://www.metoday.com
Number of Employees
Location
- Me Today Limited
- Building 10, Level 3
- 666 Great South Road
- Auckland
- 1061
- New Zealand
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MEE | NZSE (New Zealand Stock Exchange) | Yes | Ordinary Shares | NZ | NZD | Apr 2020 |
Biography
Me Today Limited, through its subsidiaries, operates as a health and wellness company in New Zealand. The company offers range of supplement products from general health to immune function, energy, sleep, ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/26 06:01 |
| End of Day Share Price | 2021/01/26 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2020/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.